Pityriasis Rosea-Like Eruption following anti-fatigue traditional herbs: Aconitum carmichaelii Debx and Panax Ginseng suspected. [PDF]
BMC Complement Med TherTraditional herbs have a history of clinical use in anti-fatigue. However, several adverse effects of herbs have been identified. Pityriasis rosea-like eruption (PR-LE) is a rare cutaneous complication of herbs.
Zeng X +7 more
europepmc +2 more sources
Atypical Rash as a Presentation of Pityriasis Rosea in a 23-Month-Old. [PDF]
CureusPityriasis rosea is a self-limiting skin disorder that can occur in pediatric patients. We report an atypical presentation of a 23-month-old male with a generalized rash similar in appearance to pityriasis rosea.
Tilak K, Ray E, Joseph M.
europepmc +2 more sources
Pityriasis Rosea With Multiple Herald Patches Resulting in a V-shaped Pattern and a Christmas Tree Distribution. [PDF]
CureusPityriasis rosea (PR), a benign and self-limiting skin disorder, typically manifests as a single initial lesion known as the herald patch. The herald patch is commonly followed by the development of secondary erythematous papules and plaques, aligning ...
Oya K, Ishii Y, Anju K, Nomura T.
europepmc +2 more sources
Indian Journal of Paediatric DermatologyPityriasis rosea, is an acute self-limiting papulosquamous inflammatory disorder. It usually starts with a herald patch on the trunk and proximal extremities, followed by scaly oval patches that give them a “Christmas tree” appearance. The lesions may be
Vidya Yadav +4 more
doaj +2 more sources
Pityriasis rosea in pregnancy: A case series and literature review. [PDF]
J Dtsch Dermatol Ges, 2022 Pityriasis rosea (PR), a common skin disease in young adults, may adversely affects the course of pregnancy and the unborn child.
Wenger-Oehn L +6 more
europepmc +2 more sources
Acral pityriasis rosea: A rare variant of pityriasis rosea [PDF]
Dermatology Reports, 2021 Pityriasis rosea (PR) is a common, selflimited inflammatory skin condition, usually affects the trunk and proximal extremities. A variety of atypical manifestations of PR have been recognized ranging from the difference in the morphology, distribution ...
Pimpa Tantanasrigul +2 more
doaj +2 more sources
The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations. [PDF]
Dermatol Ther, 2022 The article by Martora F. et al. on a series of patients with pityriasis rosea (PR) after Moderna COVID-19 vaccine 1 recently published in your journal prompted us to make some observations.
Ciccarese G, Parodi A, Drago F.
europepmc +2 more sources
Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. [PDF]
Dermatol Reports, 2023 Only a few cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after ...
Veraldi S +3 more
europepmc +2 more sources
COVID-19-associated pityriasis rosea in children: Case report and literature review. [PDF]
Clin Case Rep, 2022 Skin lesions are one of the Coronavirus disease 2019 (COVID‐19) symptoms. Pityriasis rosea (PR) is a mucocutaneous manifestation that can occur following virus infections. Most of the PR lesions after COVID‐19 infection were reported in adults.
Khalili M +3 more
europepmc +2 more sources
Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl. [PDF]
Cureus, 2022 Pityriasis rosea (PR) is an acute self-limiting exanthematous skin disorder characterized by the presence of a primary solitary lesion called a herald patch and the subsequent development of diffuse papulosquamous lesions within 1 to 2 weeks.
Bin Rubaian NF +3 more
europepmc +2 more sources